APPLICATION
ANDA214019
TYPE
ANDA
ORIGINAL APPROVAL
2024-05-08
LATEST ACTION
2024-05-08
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription
Products
DAPSONEPrescription
DAPSONE 7.5% · GEL · TOPICAL
Approval history
2024-05-08UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.